Literature DB >> 26215942

Patient-Derived Xenografts for Investigation of Acquired Resistance in Oncogene-Driven Cancers: Building a Better Mousetrap.

David R Gandara1, Primo N Lara2, Philip C Mack2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26215942     DOI： 10.1200/JCO.2015.61.9692

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  Challenges and Opportunities for Childhood Cancer Drug Development.

Authors:  Peter J Houghton; Raushan T Kurmasheva
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 2.  From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers.

Authors:  Adi F Gazdar; Fred R Hirsch; John D Minna
Journal:  J Thorac Oncol       Date:  2015-12-24       Impact factor: 15.609

3.  Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.

Authors:  Matthew C Hernandez; John R Bergquist; Jennifer L Leiting; Tommy Ivanics; Lin Yang; Rory L Smoot; David M Nagorney; Mark J Truty
Journal:  J Gastrointest Surg       Date:  2019-02-12       Impact factor: 3.452

4.  Tubulin-binding peptide RR-171 derived from human umbilical cord serum displays antitumor activity against hepatocellular carcinoma via inducing apoptosis and activating the NF-kappa B pathway.

Authors:  Donglie Zhu; Cheng Fang; Zelong Yang; Yanjie Ren; Fengrui Yang; Shi Zheng; Mingzuo Jiang; Xiangxia Miao; Duoduo Liu; Biliang Chen; Xuebiao Yao; Yong Chen
Journal:  Cell Prolif       Date:  2022-05-03       Impact factor: 8.755

Review 5.  Combine and conquer: challenges for targeted therapy combinations in early phase trials.

Authors:  Juanita S Lopez; Udai Banerji
Journal:  Nat Rev Clin Oncol       Date:  2016-07-05       Impact factor: 66.675

6.  Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma.

Authors:  Anthony R Guastella; Sharon K Michelhaugh; Neil V Klinger; William J Kupsky; Lisa A Polin; Otto Muzik; Csaba Juhász; Sandeep Mittal
Journal:  Mol Imaging       Date:  2016-05-05       Impact factor: 4.488

7.  Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.

Authors:  Qihong Zhao; Heng Zhou; Qifei Liu; Ye Cao; Gang Wang; Anla Hu; Liang Ruan; Sufang Wang; Qingli Bo; Wenjun Chen; Chuanlai Hu; Dexiang Xu; Fangbiao Tao; Jiyu Cao; Yongsheng Ge; Zongfan Yu; Li Li; Hua Wang
Journal:  Oncotarget       Date:  2016-07-26

8.  Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma.

Authors:  Mohammed Saeed Rozeik; Olfat Ali Hammam; Ali Ibrahim Ali; Mona Magdy; Heba Khalil; Amgad Anas; Ahmed Abdelaleem Abo El Hassan; Ali Abdel Rahim; Ahmed Ibrahim El-Shabasy
Journal:  Electron Physician       Date:  2017-07-25

9.  Guided chemotherapy based on patient-derived mini-xenograft models improves survival of gallbladder carcinoma patients.

Authors:  Ming Zhan; Rui-Meng Yang; Hui Wang; Min He; Wei Chen; Sun-Wang Xu; Lin-Hua Yang; Qiang Liu; Man-Mei Long; Jian Wang
Journal:  Cancer Commun (Lond)       Date:  2018-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.